MedPath

Naphcon-A

Brand Name: Naphcon-A

Generic Name: Pheniramine Maleate/ Naphazoline Hydrochloride

Active
Registration Number

DR-XY4858

Dosage Form

Ophthalmic Solution

Issuance Date

July 6, 2022

Expiry Date

September 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength3 mg/ 250 mcg/mL
PackagingPlastic Droptainer Dispenser x 15 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antihistamines/ Decongestants
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Pheniramine Maleate/ Naphazoline HydrochlorideActive
Monograph: pheniramine maleate/ naphazoline hydrochloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform